Centers for Medicare & Medicaid Services (CMS) recently released its List of Measures under Consideration.
One of the measures under consideration is MUC17-210 which measures “Hospital Harm Performance Measure: Opioid Related Adverse Respiratory Events”:
“This measure will assess opioid related adverse respiratory events (ORARE) in the hospital setting. The goal for this measure is to assess the rate at which naloxone is given for opioid related adverse respiratory events that occur in the hospital setting, using a valid method that reliably allows comparison across hospitals.”
Continue reading “CMS Proposes Measuring Opioid Related Adverse Respiratory Events”